Many couples struggling to conceive are looking for a gentle, effective, and scientifically proven treatment method. With OvulaRing For the first time, a medical device is available that comprehensively tracks the female cycle, thereby offering a completely new Menstrual Cycle Monitoring enables.
Based on these precise measurements, the CFG score developed to help doctors assess fertility on an individual basis and create a personalized Treatment Plan for Those Hoping to Conceive This allows for the identification of specific cycle patterns, the targeted treatment of hormonal imbalances, and a significant increase in the chances of pregnancy.
OvulaRing provides a complete record of the female menstrual cycle, opening up new possibilities in gynecological practice. In addition, this continuous measurement of core body temperature enables a new level of diagnostic accuracy. This also makes new treatments possible for women struggling to conceive.
OvulaRing is a Class IIa medical device under the MDR, developed by gynecologists and extensively tested: clinical evidence & Studies on OvulaRing
In addition to accurately determining ovulation within the cycle, OvulaRing can provide further important information about the state of the cycle. The length of the luteal phase is crucial for assessing a cycle’s fertility. This can be precisely determined using OvulaRing. To this end, Prof. Alexander developed a scoring system for cycle characteristics based on the length of the luteal phase*. Scores range from A to E, where Score A indicates a cycle with a pregnancy and E indicates a cycle without ovulation. The closer the score is to A, the more fertile the cycle.
*Alexander H. In: Ärzteblatt Sachsen; 12: 539–542. (2015) The cyclofertilogram for accurate cycle and fertility diagnosis.
Continuous tracking of at least three consecutive cycles using OvulaRing forms the basis for treating infertility based on the CFG score. Depending on the cycle characteristics identified by OvulaRing in each cycle, various treatment options may be available. Generally speaking, the closer the CFG score is to score A, the higher the fertility of the cycle.
If monophasic cycles (Score E) occur frequently, inducing ovulation may increase the likelihood of a fertile cycle. However, if this does not lead to success, the patient should be referred to a fertility clinic for comprehensive evaluation.
In Score D, a luteal phase is present following ovulation. However, at 8 to 10 days, the luteal phase is relatively short. In this case, the corpus luteum may produce too little progesterone to sustain the period until a fertilized egg implants. In this situation, treatment with progesterone or retroprogesterone is recommended.
Score C most closely corresponds to the standard cycle, with a luteal phase that lasts an average of 13 days. The corpus luteum produces enough progesterone to optimally support an emerging pregnancy.
With Score B, the length of the luteal phase is above average (16 to 19 days). The corpus luteum produces more than enough progesterone to support an emerging pregnancy.
In this case, pregnancy does not occur despite the presence of cycles with a sufficiently long luteal phase (B and C) or following progesterone administration. The next steps involve examining the man’s sperm in a semen analysis and the woman’s fallopian tube patency. If these results are normal, it is possible that the available fertile days were not utilized appropriately.
Regular sex during the fertile days—ideally 2 or 3 times during the fertile phase of each cycle—is recommended. OvulaRing accurately identifies individual cycle patterns and provides optimal support for timing intercourse correctly.
If your temperature remains elevated for 20 days or more after ovulation, you are most likely pregnant.
“Only with OvulaRing can you obtain complete measurements. Thanks to continuous measurement, you get a very accurate overview of your cycle.”
“I find this ring intelligent and at the same time very easy to use. As a result, it is really patient-friendly. That's what convinced me!”
“OvulaRing provides an accurate and detailed record of the menstrual cycle. This data makes it possible to develop a personalized treatment plan.”
"OvulaRing is a simple method for tracking the menstrual cycle in women who are trying to conceive. In this regard, it can very accurately indicate the timing of the fertile window."
For the third time in a row, OvulaRing has received the coveted award in the “Cycle Tracker/Computer” category. We are grateful for the award and proud of what we have already achieved with OvulaRing.
Despite endometriosis, unsuccessful IVF attempts, and having only one fallopian tube, she got pregnant using the OvulaRing: "But with the ring, I could tell right away that my body was doing everything right! That really helped me regain my trust in my body."
Lisa's Testimonial
"I was immediately impressed by OvulaRing. It took the pressure off me to constantly track my cycle. I got pregnant right away during my first cycle, even though I ovulated on day 32!"
"After I stopped taking the pill, my cycles got longer and longer. I started using OvulaRing because regular ovulation tests weren't reliable for me."
"I'm currently breastfeeding my 1-year-old son. Also, I haven't had my period yet. Thanks to OvulaRing, I'm getting to know my cycle better again. And, by the way, without having to think about it at all."
"After two years of trying unsuccessfully to conceive, visits to the fertility clinic, and three rounds of artificial insemination, I was finally pregnant. I've never tried a more convenient way to track my cycle. This ring is an absolute game-changer for all women!"
"I would definitely recommend OvulaRing. After all, OvulaRing helped us have our wonderful daughter."
"Thanks!"
“For me, OvulaRing is the perfect solution for tracking my fertile days despite my long and irregular cycles. Thanks to OvulaRing, I now know for sure that I’m ovulating and when it happens.”
Join our newsletter and get your 10% discount for your starter package. Enter your email to continue.
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Newsletter2Go. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Trustpilot. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information